Advertisement
Table 1 Patient characteristics
| Overall (n = 190) | |
|---|---|
| Clinical | |
| Age (years) | 57 ± 12 |
| Male gender | 87% (165) |
| Body surface area | 2.0 ± 0.2 |
| Coronary Artery Disease Risk Factors | |
| Hypertension | 47% (90) |
| Hypercholesterolemia | 54% (102) |
| Diabetes mellitus | 28% (53) |
| Tobacco use | 35% (66) |
| Family history | 30% (56) |
| Cardiovascular Medications | |
| Beta-blocker | 91% (173) |
| ACEI/ARB | 60% (113) |
| Loop diuretic | 15% (28) |
| Statin | 93% (177) |
| Aspirin | 98% (186) |
| Thienopyridine | 83% (158) |
| Warfarin | 5% (9) |
| Nitroglycerin | 13% (25) |
| Cardiac morphology/function | |
| Left Ventricle | |
| Ejection fraction (%) | 52.2 ± 13.3 |
| LV dysfunction (EF < = 55%) | 55% (105) |
| End-diastolic volume (ml) | 161.9 ± 49.2 |
| End-systolic volume (ml) | 81.6 ± 46.4 |
| Myocardial mass (g) | 137.9 ± 38.2 |
| Late gadolinium enhancement (present) | 98% (186) |
| Infarct size (% myocardium) | 14.5 ± 10.4 |
| Aortic Valve | |
| Bileaflet | 2% (3) |
| Thickening/ fibrocalcific changes | 12% (23) |
| Stenosis | 2% (4) |
| Regurgitation | 7% (13) |
